Rareş Drulă
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- Melanoma and MAPK Pathways
- RNA modifications and cancer
- Extracellular vesicles in disease
Papers in
-
- Circular RNAs in diseases 5
- Ubiquitin and proteasome pathways 3
- Protein Degradation and Inhibitors 2
- Histone Deacetylase Inhibitors Research 2
-
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 5
- Co-authors
- Cornelia Braicu (5 shared papers)Călin Ionescu (2 shared papers)Alexandru Irimie (2 shared papers)Diana Gulei (7 shared papers)Alexandru Rusu (1 shared paper)Constantin Busuioc (1 shared paper)Mihail Buse (1 shared paper)Lajos Ráduly (2 shared papers)
- Journals
- Cancers (3 papers)Blood Reviews (2 papers)Wiley Interdisciplinary Reviews - RNA (2 papers)International Journal of Molecular Sciences (2 papers)Journal of Cellular and Molecular Medicine (2 papers)
- Partner nations
- RomaniaUnited StatesCzechia
In The Last Decade
Rareş Drulă
17 papers receiving 907 citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Cancer Research 292
- Molecular Biology 601
- Oncology 189
- Pathology and Forensic Medicine 84
- Toxicology 13
Countries citing papers authored by Rareş Drulă
This map shows the geographic impact of Rareş Drulă's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rareş Drulă with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rareş Drulă more than expected).
Fields of papers citing papers by Rareş Drulă
This network shows the impact of papers produced by Rareş Drulă. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rareş Drulă. The network helps show where Rareş Drulă may publish in the future.
Co-authors
The 25 scholars most cited alongside Rareş Drulă, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer Hit paper breakdown → | 2019 | 671 |
| 2 | 2020 | 47 | |
| 3 | 2020 | 35 | |
| 4 | 2019 | 32 | |
| 5 | 2021 | 27 | |
| 6 | 2020 | 26 | |
| 7 | 2024 | 14 | |
| 8 | 2023 | 12 | |
| 9 | 2023 | 11 | |
| 10 | 2023 | 10 | |
| 11 | 2022 | 10 | |
| 12 | 2021 | 9 | |
| 13 | 2024 | 3 | |
| 14 | 2024 | 2 | |
| 15 | 2023 | 2 | |
| 16 | 2024 | 2 | |
| 17 | 2024 | 1 | |
| 18 | 2024 | 0 |
About Rareş Drulă
Rareş Drulă is a scholar working on Molecular Biology, Cancer Research, Hematology, Pulmonary and Respiratory Medicine and Oncology, having authored 18 papers that have together received 914 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (5 papers), Ubiquitin and proteasome pathways (3 papers), Protein Degradation and Inhibitors (2 papers), Renal cell carcinoma treatment (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Cancer Research (292 citations), Molecular Biology (601 citations), Oncology (189 citations), Pathology and Forensic Medicine (84 citations) and Toxicology (13 citations). Rareş Drulă has collaborated with scholars based in Romania, United States and Czechia. Frequent co-authors include Cornelia Braicu, Călin Ionescu, Alexandru Irimie, Diana Gulei, Alexandru Rusu, Constantin Busuioc, Mihail Buse, Lajos Ráduly, Atanas G. Atanasov and Ioana Berindan‐Neagoe. Their work appears in journals such as Cancers, Blood Reviews, Wiley Interdisciplinary Reviews - RNA, International Journal of Molecular Sciences and Journal of Cellular and Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.